Henry J. Riordan

Chief Development Officer at Worldwide Clinical Trials

Henry Riordan has a diverse and extensive work experience in the medical and pharmaceutical industry. Henry has held various leadership positions in different companies. From 1987 to 1988, they worked as a Counselor at NewMedico. Henry then joined Dartmouth Hitchcock Medical Center in 1993 as an Assistant Professor in Neuropsychiatry until 1997. From 1997 to 1998, they worked as an Assistant Professor in the Department of Neurology at Jefferson Medical College. Henry then joined UnitedHealth Group/i3, Division of Ingenix Pharmaceutical Services in 1998 and held several positions, including Vice President and Global Head of Medical and Scientific Affairs until 2008. Since 2008, they have been working at Worldwide Clinical Trials, where they have held the roles of Executive Vice President and Global Franchise Leader Neuroscience and currently serves as the Chief Development Officer.

Henry Riordan has an extensive education history in the field of neuropsychology. Henry obtained a PhD in Biopsychology, specializing in Neuropsychology, from Stony Brook University, where they also earned a Master's degree in Biopsychology. Prior to that, they completed a Master's degree in Experimental Psychology: Quantitative Methods from the University of Hartford. Henry began their undergraduate studies at Bloomsburg University of Pennsylvania and received a Bachelor's degree in Psychology and Biology. Henry completed their high school education at Sharon Hill High School. Additionally, they completed postdoctoral training at the Geisel School of Medicine at Dartmouth and the University of Pennsylvania School of Medicine.

Links

Previous companies

UnitedHealth Group logo

Timeline

  • Chief Development Officer

    October, 2019 - present